Since we detected a constant hypermethylation of RASSF1A in all of the different stages of the breast carcinomas we can suggest that hypermethylation of RASSF1A is an early event during breast cancer pathogenesis and also the main mechanism of inactivation. This evidence concerns the gene RASSF1 and breast cancer.